Expect margins to continue to improve on higher offtake and lower input costs, says Balaji Amines

"We are targeting more than 25–30% of the total revenue for the exports. We are gearing up with the new product lineup; there should be 1.5–2% growth in exports in the coming quarters," Reddy explained during the interview.

Balaji Amines has set ambitious targets for its future revenues, expecting ₹2,000 crore in FY25 and ₹3,000 crore in FY26, with an accompanying margin of 24%.

"With the current rate, we should be in a position to complete a minimum ₹1,700-1,800 crore annual turnover for the current financial year. For the next financial year, we should be touching about ₹2,000 crore with these raw material prices and finished products prices, but for 2026, we are targeting a minimum ₹3,000 crore annual turnover with all these expansions going forward," he said.

Anticipating significant expansions, Reddy stated, “Before the end of 2025, we should be in a position to commission two major plants; one is a methylamine plant with a 40,000-tonne capacity, and the other is a di-methyl ether plant—the first of its kind in the country—with a 100,000-tonne capacity, which will be commissioned by March 2025. There is also a solar power plant of 20 megawatts (MW).”

Balaji Amines is actively working towards becoming a key player in the market, with a market cap of ₹7,897 crore. The company is headquartered in Solapur, Maharashtra, India, and is strategically positioned to capitalise on the evolving market dynamics, focusing on increased exports, lower raw material costs, and higher offtake to drive future growth.